Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
Other Items
Atara Biotherapeutics Inc
Other Items Peer Comparison
Competitive Other Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Other Items
$125.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Items
-$1.2B
|
CAGR 3-Years
68%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Items
-$1.7B
|
CAGR 3-Years
52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Items
-$26.8B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Items
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-93%
|
CAGR 10-Years
-101%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Items
-$3.8B
|
CAGR 3-Years
-212%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-32%
|
See Also
What is Atara Biotherapeutics Inc's Other Items?
Other Items
125.1m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Other Items amounts to 125.1m USD.
What is Atara Biotherapeutics Inc's Other Items growth rate?
Other Items CAGR 1Y
-40%
Over the last year, the Other Items growth was -40%.